Gastroenterol Res
Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website http://www.gastrores.org

Original Article

Volume 10, Number 3, June 2017, pages 172-176


High C-Reactive Protein and Low Albumin Levels Predict High 30-Day Mortality in Patients Undergoing Percutaneous Endoscopic Gastrotomy

Omer Karasahina, Pinar Tosun Tasarb, f, Ozge Timurc, Dogan Nasir Binicic, Tugba Kiper Yilmazc, Adem Asland, Sevnaz Sahine

aInfectious Diseases Clinic, Erzurum Regional Training and Research Hospital, Erzurum, Turkey
bGeriatrics Clinic, Erzurum Regional Training and Research Hospital, Erzurum, Turkey
cInternal Medicine Clinic, Erzurum Regional Training and Research Hospital, Erzurum, Turkey
dGeneral Surgery Clinic, Erzurum Regional Training and Research Hospital, Erzurum, Turkey
eDepartment of Internal Medicine, Department of Geriatrics, Ege University School of Medicine, Izmir, Turkey
fCorresponding Author: Pinar Tosun Tasar, Geriatrics Clinic, Erzurum Regional Training and Research Hospital, Erzurum, Turkey

Manuscript submitted May 20, 2017, accepted May 31, 2017
Short title: High CRP and Low Albumin in PEG Mortality
doi: https://doi.org/10.14740/gr862w

Abstract▴Top 

Background: Percutaneous endoscopic gastrotomy (PEG) enables long-term enteral feeding. The aim of this study was to identify biomarkers that may guide the decision of whether to perform the elective procedure of PEG.

Methods: The medical records of all patients who underwent PEG in our hospital from 2010 to 2016 were screened retrospectively. Patients with mortality within a 30-day follow-up period and those without were compared using the Chi-square test, and continuous variables were compared with the Kruskal-Wallis and Mann-Whitney U tests. Receiver operating characteristic (ROC) curve analysis was used to demonstrate the ability of biomarkers to predict mortality; a cut-off point was determined and its sensitivity, specificity, and positive and negative predictive values were calculated. The Youden index was used to determine the cut-off point. Kaplan-Meier analysis was used to identify PEG-related mortality risk factors and a Cox regression model was applied for risk characterization.

Results: A total of 120 patients who underwent PEG were evaluated in the study. The mean age was 67.00 ± 18.00 years. The most common indication for PEG was cerebrovascular disease, in 69 (57.5%) of the patients. Infection of the PEG site was most common within 14 days after PEG tube placement, occurring in 13 patients (10.3%). The mortality rate among patients with post-PEG infection was 68.2%, significantly higher than in patients without infection (P = 0.012). Thirty-four patients (28.3%) died within 30 days of undergoing PEG. CRP values ≥ 78.31 mg/L increased mortality by 8.756-fold, and albumin levels < 2.71 g/dL increased mortality by 2.255-fold.

Conclusion: Our results indicate that the presence of both high CRP level and low albumin level were associated with significantly higher rate of mortality (73.1%) in patients who underwent PEG.

Keywords: Mortality; PEG

Introduction▴Top 

The purpose of enteral nutrition is to protect gastrointestinal mucosal integrity, thereby maintaining mucosal barrier function, intestinal immunity, and the normal flora [1]. Percutaneous endoscopic gastrostomy (PEG) allows long-term enteral feeding through a gastrostomy tube for various indications causing malnutrition in patients with normally functioning bowels [2].

In the literature, 30-day mortality rates reported for patients with PEG range from 2.4% to 22.5% [2-5]. It has been emphasized that short-term, less invasive methods like nasogastric (NG) feeding may be preferable in cases where the patient is unlikely to survive for 30 days after PEG placement [6]. Therefore, in this study, we aimed to identify biomarkers that may guide the decision of whether to perform the elective procedure of PEG.

Materials and Methods▴Top 

We included all patients who underwent PEG at the Erzurum Regional Hospital between January 1, 2010 and December 31, 2016. Data were collected by retrospective screening of patients’ medical records and the hospital records system. Categorical descriptive data were expressed as frequency distribution and percentage; continuous variables were expressed as mean ± standard deviation and median (maximum - minimum).

Definition of infection site

Aspiration pneumonia refers to the pulmonary consequences resulting from this abnormal entry of fluid, particulate exogenous substances, or endogenous secretions into the lower airways [7].

The presence of the following criteria is necessary to diagnose aspiration pneumonia [8]: 1) infiltration in chest X-ray; 2) the presence of at least one of the major criteria (cough, sputum, fever) or at least one of the minor criteria (dyspnea, chest pain, consciousness change, consensus on physical examination, leukocyte count 12,000 and above); and 3) aspiration to be witnessed or to find a risk factor for aspiration.

PEG site infection was defined to be positive if three or more of the following criteria were observed: erythema, induration, exudate and/or purulent secretion [9].

Blood stream infection required one of the following: 1) recognized pathogen in the blood and pathogen not related to an infection at another site; or 2) fever, chills, or hypotension; and any of the following: 1) a common skin contaminant is isolated from at least two blood cultures drawn on separate occasions, and the organism is not related to infection at another site; 2) a common skin contaminant is isolated from blood culture in a patient with an intravascular device, and the physician institutes appropriate antimicrobial therapy; 3) a positive antigen test on blood and the organism is not related to infection at another site [10].

Bloodstream infection is the isolation of a bacterial or fungus originating in the blood stream of an infection at any anatomical site of the body [10].

Patients with mortality within 30 days and those who survived for more than 30 days after the PEG procedure were compared using the Chi-square test. Continuous variables did not meet the assumptions of parametric hypothesis and were compared with the non-parametric Kruskal-Wallis and Mann-Whitney U tests.

Receiver operating characteristic (ROC) curve analysis was used to demonstrate the predictive value of albumin, C-reactive protein (CRP), lymphocyte ratio, hemoglobin, and leukocyte number on mortality. A cut-off point was determined and its sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated. The Youden index (J = sensitivity + specificity - 1) was used to determine the cut-off point.

Kaplan-Meier (log-rank) analysis was used to identify PEG-related mortality risk factors, then a Cox regression model was applied for risk characterization (model: forward: likelihood ratio (LR) entry: 0.05 and removal: 0.10).

P < 0.05 was accepted as statistically significant. Data were analyzed using SPSS 15.0 statistical software package.

Results▴Top 

A total of 120 patients who underwent PEG were evaluated in the study. The mean age was 67.00 ± 18.00 years and median age was 72 years (range, 16 - 90 years). Seventy (58.3%) of the patients were male. The most common indication for PEG was cerebrovascular disease, present in 69 (57.5%) of the patients (Table 1).

Table 1.
Click to view
Table 1. Characteristics of Patients Who Underwent PEG
 

Within 14 days after PEG placement, 13 patients (10.3%) developed infection of the PEG site, six patients (5.0%) had bloodstream infections, and three patients (2.5%) developed aspiration pneumonia. The mortality rate among patients with post-PEG infection was 68.2%, significantly higher than in patients without infection (P = 0.012). The distribution of infectious agent according to infection type is presented in Table 2.

Table 2.
Click to view
Table 2. Distribution of the Microbial Agents of Infections Developed After Percutaneous Endoscopic Gastrotomy
 

Thirty-four patients (28.3%) died within 30 days of undergoing PEG. Of these patients, 64.4% were in the intensive care unit. Mortality was significantly higher among patients in intensive care compared to those whose PEG was performed in inpatient units (P < 0.001). Table 3 shows the patients’ comorbid conditions and biomarker levels assessed on the day PEG was performed, grouped according to 30-day mortality.

Table 3.
Click to view
Table 3. Biomarker Levels and Comorbidities in Patients Based on 30-Day Mortality
 

Analysis of the biomarkers’ diagnostic power is presented in Table 4. CRP value was found to have the greatest diagnostic power (area under the curve: 82.5% (confidence interval: 74.9-90.2%)).

Table 4.
Click to view
Table 4. Evaluation of Biomarkers Using ROC Analysis
 

The Cox regression analysis included variables which emerged as significant in Kaplan-Meier analysis: lymphocyte and neutrophil percentages, CRP, albumin, hemoglobin, leukocyte count, and coronary artery disease. CRP values ≥ 78.31 mg/L increased mortality by 8.756-fold, and albumin levels < 2.71 g/dL increased mortality by 2.255-fold (confidence interval: 1.110 - 4.579, P = 0.024).

A graph of 30-day survival using both CRP and albumin is shown in Figure 1. Patients with CRP values under 78.3 mg/L had a median survival of 28.6 days (27.3 - 30.0 days), while patients with CRP values over 78.3 mg/L had a median survival of 20.2 days (17.4 - 23.0 days). Patients with albumin levels under 2.71 g/dL had median survival of 21.3 days (18.2 - 24.5 days), whereas patients with albumin levels over 2.71 g/dL had a mean survival of 27.1 days (25.5 - 28.7 days).

Figure 1.
Click for large image
Figure 1. Survival graph based on CRP and albumin.
Discussion▴Top 

PEG allows long-term feeding via enteral nutrition for patients who are unable to take oral nutrition [11]. Being a surgical procedure, PEG introduces various complications. PEG-related complications are reported in 13.2-50% of patients who undergo the procedure [5, 12, 13]. The most important of these complications are aspiration pneumonia, esophageal perforation, bleeding, tube occlusion, anesthesia-related side effects, and infection of the wound site [11]. The incidence of local or life-threatening systemic infections following PEG is reported as 4-60% [14, 15]. The infection rate among patients analyzed in our study was 18.8% and most infections were at the incision site, consistent with the literature. Similar to previous studies, the infectious agents we identified were predominantly gram-negative microorganisms, but we also detected polymicrobial infections in our study [16]. In the literature, the 30-day mortality rate for PEG patients has been reported as 2.4-22.5% [2-5]. Compared to previous studies, the 30-day mortality rate in our study was high at 28.3%. This is likely related to the high mortality rate among patients who underwent PEG in intensive care (66.4%). Due to the high mortality rates and complications, our objective in the present study was to identify biomarkers that may guide the decision to perform PEG.

Albumin and CRP levels have been used in PEG patients to predict short-term mortality and detect acute conditions which may affect prognosis [4, 17-20]. Bloomberg et al found that CRP level over 10 mg/L and albumin under 3.0 g/dL was an independent risk factor for post-PEG mortality. In addition, using those cut-off points, the authors demonstrated a 20.5% mortality rate among patients with high CRP and low albumin levels [4]. In a similar study, the mortality rate was approximately 60% among patients with CRP over 21.5 mg/L and albumin under 3.15 g/dL [5]. Another study that identified CRP elevation after PEG as an independent risk factor reported a mortality rate of 18% at CRP levels over 50 mg/L. The cut-off point for low albumin level as an independent risk factor for post-PEG mortality in dementia patients was reported as 2.8 g/dL [20]. Cut-off points in our study were 78.3 mg/L for CRP and 2.71 g/dL for albumin. Consistent with previous studies, these biomarkers were identified as an independent risk factor for mortality, with 73.1% of the patients with high CRP/low albumin levels surviving less than 30 days post-PEG.

We determined a higher cut-off value for CRP than that reported in previous studies. This may be due to the inclusion in our study of patients in intensive care, patients on mechanical ventilators, and patients at high risk of infection. Although elevated CRP does not reflect a patient’s overall condition and may be considered a limitation of the present study, we believe it is effective for our purpose because it serves as evidence of infection and indicates that PEG should be postponed.

Low albumin and high CRP levels have been reported previously as indicators of malnutrition, inflammation, and postoperative infection [4, 21, 22]. As PEG is not an emergent procedure, it can be deferred; authors have reported that it can be performed after an underlying acute condition is investigated. Meanwhile, nutritional support can be provided via less invasive methods such as parenteral feeding or nasogastric catheter [4]. Therefore, caution must be exercised when deciding when to perform PEG, as with any elective surgical intervention, especially in patients with high CRP and low albumin levels.

Conclusion

Our results indicate that the presence of both high CRP level and low albumin level were associated with significantly higher rate of mortality (73.1%) in patients who underwent PEG. High CRP and low albumin levels undoubtedly constitute a mortality risk for all surgical procedures. Furthermore, low albumin levels are an indicator of malnutrition, which is the reason PEG is performed. However, patients who die within 30 days are not able to benefit from PEG. Therefore, guided by albumin and CRP, underlying acute conditions must be identified and alleviated. We believe that providing nutritional support by alternative routes allows the PEG procedure to be deferred until it is safer to perform.


References▴Top 
  1. Onder A, Kapan M, Arikanoglu Z, Gul M, Bestas R, Palanci Y, Karaman H, et al. Percutaneous endoscopic gastrostomy: mortality and risk factors for survival. Gastroenterology Res. 2012;5(1):21-27.
    doi
  2. Grant MD, Rudberg MA, Brody JA. Gastrostomy placement and mortality among hospitalized Medicare beneficiaries. JAMA. 1998;279(24):1973-1976.
    doi pubmed
  3. Laskaratos FM, Walker M, Gowribalan J, Gkotsi D, Wojciechowska V, Arora A, Jenkins A. Predictive factors for early mortality after percutaneous endoscopic and radiologically-inserted gastrostomy. Dig Dis Sci. 2013;58(12):3558-3565.
    doi pubmed
  4. Blomberg J, Lagergren P, Martin L, Mattsson F, Lagergren J. Albumin and C-reactive protein levels predict short-term mortality after percutaneous endoscopic gastrostomy in a prospective cohort study. Gastrointest Endosc. 2011;73(1):29-36.
    doi pubmed
  5. Lee C, Im JP, Kim JW, Kim SE, Ryu DY, Cha JM, Kim EY, et al. Risk factors for complications and mortality of percutaneous endoscopic gastrostomy: a multicenter, retrospective study. Surg Endosc. 2013;27(10):3806-3815.
    doi pubmed
  6. Jain R, Maple JT, Anderson MA, Appalaneni V, Ben-Menachem T, Decker GA, Fanelli RD, et al. The role of endoscopy in enteral feeding. Gastrointest Endosc. 2011;74(1):7-12.
    doi pubmed
  7. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med. 2001;344(9):665-671.
    doi pubmed
  8. Leroy O, Vandenbussche C, Coffinier C, Bosquet C, Georges H, Guery B, Thevenin D, et al. Community-acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data. Am J Respir Crit Care Med. 1997;156(6):1922-1929.
    doi pubmed
  9. Zopf Y, Konturek P, Nuernberger A, Maiss J, Zenk J, Iro H, Hahn EG, et al. Local infection after placement of percutaneous endoscopic gastrostomy tubes: a prospective study evaluating risk factors. Can J Gastroenterol. 2008;22(12):987-991.
    doi pubmed
  10. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16(3):128-140.
    doi
  11. Abuksis G, Mor M, Segal N, Shemesh I, Plout S, Sulkes J, Fraser GM, et al. Percutaneous endoscopic gastrostomy: high mortality rates in hospitalized patients. Am J Gastroenterol. 2000;95(1):128-132.
    doi pubmed
  12. Pruthi D, Duerksen DR, Singh H. The practice of gastrostomy tube placement across a Canadian regional health authority. Am J Gastroenterol. 2010;105(7):1541-1550.
    doi pubmed
  13. Sheehan JJ, Hill AD, Fanning NP, Healy C, McDermott EW, O'Donoghue DP, O'Higgins NJ. Percutaneous endoscopic gastrostomy: 5 years of clinical experience on 238 patients. Ir Med J. 2003;96(9):265-267.
    pubmed
  14. Schapiro GD, Edmundowicz SA. Complications of percutaneous endoscopic gastrostomy. Gastrointest Endosc Clin N Am. 1996;6(2):409-422.
    pubmed
  15. Chowdhury MA, Batey R. Complications and outcome of percutaneous endoscopic gastrostomy in different patient groups. J Gastroenterol Hepatol. 1996;11(9):835-839.
    doi
  16. Rolston KV, Mihu C, Tarrand JJ. Current microbiology of percutaneous endoscopic gastrostomy tube (PEG tube) insertion site infections in patients with cancer. Support Care Cancer. 2011;19(8):1267-1271.
    doi pubmed
  17. Lang A, Bardan E, Chowers Y, Sakhnini E, Fidder HH, Bar-Meir S, Avidan B. Risk factors for mortality in patients undergoing percutaneous endoscopic gastrostomy. Endoscopy. 2004;36(6):522-526.
    doi pubmed
  18. Martin L, Lagergren J, Blomberg J, Johar A, Bosaeus I, Lagergren P. Phase angle as a prognostic marker after percutaneous endoscopic gastrostomy (PEG) in a prospective cohort study. Scand J Gastroenterol. 2016;51(8):1013-1016.
    doi pubmed
  19. Figueiredo FA, da Costa MC, Pelosi AD, Martins RN, Machado L, Francioni E. Predicting outcomes and complications of percutaneous endoscopic gastrostomy. Endoscopy. 2007;39(4):333-338.
    doi pubmed
  20. Higaki F, Yokota O, Ohishi M. Factors predictive of survival after percutaneous endoscopic gastrostomy in the elderly: is dementia really a risk factor? Am J Gastroenterol. 2008;103(4):1011-1016; quiz 1017.
    doi pubmed
  21. Stephens NA, Skipworth RJ, Fearon KC. Cachexia, survival and the acute phase response. Curr Opin Support Palliat Care. 2008;2(4):267-274.
    doi pubmed
  22. McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67(3):257-262.
    doi pubmed


This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.


Gastroenterology Research is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Gastroenterology Research, bimonthly, ISSN 1918-2805 (print), 1918-2813 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.

This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.gastrores.org   editorial contact: editor@gastrores.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.